Stellar Pharmaceuticals
English        Pour nous joindre     1-800-639-0643          

Navigation

Pour nous joindre

Stellar Pharmaceuticals Inc.
54, rue Egerton
London (Ontario) N5W 3Z8
Tél. : 1-800-639-0643
Fax : 519-434-4382

Communiqués de presse

   2   
Date de sortie Titre (cliquer pour lire)
12/01/2011 Stellar to Acquire Tribute Pharmaceuticals to Create Premier North American Specialty Pharmaceutical Company
11/14/2011 Stellar Pharmaceuticals Reports Third Quarter 2011 Financial Results
09/13/2011 Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
08/17/2011 Stellar Pharmaceuticals Issued Uracyst(R) Patent in Japan
08/15/2011 Stellar Pharmaceuticals Reports Second Quarter 2011 Financial Results
06/08/2011 Stellar Pharmaceuticals Engages Advisory Consultant for Its Products in the United States Market
05/16/2011 Stellar Pharmaceuticals Reports First Quarter 2011 Financial Results
04/13/2011 Stellar Pharmaceuticals Inc. and Watson Pharmaceuticals, Inc. Terminate Uracyst(R) Supply and Licensing Agreements
03/31/2011 Stellar Pharmaceuticals Profitable for 2010; Revenues Up 32% & Net Profit Up 120%
03/15/2011 Stellar Pharmaceuticals Engages Seasoned Business Development Consultant
03/07/2011 Stellar's Common Shares Now Trading on OTCQB
01/18/2011 Stellar Pharmaceuticals Announces Retirement of Peter Riehl as CEO, President and Director
01/06/2011 Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
11/16/2010 Stellar Pharmaceuticals Provides Further Update on the Watson Ur008 Pilot Study of Uracyst(R)
11/10/2010 Stellar Pharmaceuticals Provides Update on Watson's U.S. Pilot Study of Uracyst(R)
11/09/2010 Stellar Pharmaceuticals Reports Third Quarter 2010 Financial Results
10/11/2010 Stellar Pharmaceuticals Announces Completion of Non-Brokered Private Placement
10/05/2010 Stellar Pharmaceuticals Announces Non-Brokered Private Placement
08/11/2010 Stellar Pharmaceuticals Inc. to Present at Global Hunter Investor Conference
08/06/2010 Stellar Pharmaceuticals Reports Second Quarter 2010 Financial Results
   2   
© 2024 Stellar Pharmaceuticals Inc. Tous droits réservés.